Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Howell

Showing results (121-130 of 339) with videos related to

Pageof 34
Sort By:
Cell Cycle (Georgetown, Tex.)|October 23, 2012
Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cellsUbaldo E Martinez-Outschoorn, Zhao Lin, Diana Whitaker-Menezes, et al.
Cell Cycle (Georgetown, Tex.)|October 23, 2012
Ketone body utilization drives tumor growth and metastasisUbaldo E Martinez-Outschoorn, Zhao Lin, Diana Whitaker-Menezes, et al.
BMC Cancer|May 30, 2021
Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?Lorna McWilliams, Victoria G Woof, Louise S Donnelly, et al.
Cancer Treatment Reviews|July 22, 2011
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic reviewJavaid Iqbal, Ophira M Ginsburg, Thiwanka D Wijeratne, et al.
Cancers|October 14, 2022
Implementing Risk-Stratified Breast Screening in England: An Agenda Setting MeetingLorna McWilliams, D Gareth Evans, Katherine Payne, et al.
BMC Medical Informatics and Decision Making|October 3, 2014
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?Mattia C F Prosperi, Sarah L Ingham, Anthony Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trialAlistair Ring, Ivana Sestak, Michael Baum, et al.
Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.
Nature Clinical Practice. Oncology|December 13, 2005
Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactionsAnthony Howell, Andrew H Sims, Kai Ren Ong, et al.
Journal of Medical Genetics|March 30, 2013
Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2Sarah Louise Ingham, Jane Warwick, Iain Buchan, et al.
Pageof 34

Showing results (121-130 of 339) with videos related to

Sort By:
Pageof 34
Cell Cycle (Georgetown, Tex.)|October 23, 2012
Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cellsUbaldo E Martinez-Outschoorn, Zhao Lin, Diana Whitaker-Menezes, et al.
Cell Cycle (Georgetown, Tex.)|October 23, 2012
Ketone body utilization drives tumor growth and metastasisUbaldo E Martinez-Outschoorn, Zhao Lin, Diana Whitaker-Menezes, et al.
BMC Cancer|May 30, 2021
Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?Lorna McWilliams, Victoria G Woof, Louise S Donnelly, et al.
Cancer Treatment Reviews|July 22, 2011
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic reviewJavaid Iqbal, Ophira M Ginsburg, Thiwanka D Wijeratne, et al.
Cancers|October 14, 2022
Implementing Risk-Stratified Breast Screening in England: An Agenda Setting MeetingLorna McWilliams, D Gareth Evans, Katherine Payne, et al.
BMC Medical Informatics and Decision Making|October 3, 2014
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?Mattia C F Prosperi, Sarah L Ingham, Anthony Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trialAlistair Ring, Ivana Sestak, Michael Baum, et al.
Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.
Nature Clinical Practice. Oncology|December 13, 2005
Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactionsAnthony Howell, Andrew H Sims, Kai Ren Ong, et al.
Journal of Medical Genetics|March 30, 2013
Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2Sarah Louise Ingham, Jane Warwick, Iain Buchan, et al.
Pageof 34